COYA
Coya Therapeutics Inc.
$6.06
-$0.26(-4.11%)
52
Overall
60
Value
50
Tech
47
Quality
Market Cap
$106.37M
Volume
93.72K
52W Range
$4.65 - $8.29
Target Price
$16.20
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| REVENUE | |||||
| Total Revenue | -- | $6.0M | $3.6M | ||
| Total Revenue | -- | $6.0M | $3.6M | ||
| GROSS PROFIT | |||||
| Gross Profit | -- | $6.0M | $3.6M | ||
| OPERATING EXPENSES | |||||
| Operating Expenses | $9.8M | $13.9M | $20.8M | ||
| Research & Development | $4.4M | $5.5M | $11.9M | ||
| Research Expense | $4.4M | $5.5M | $11.9M | ||
| Selling, General & Administrative | $4.8M | $7.8M | $8.9M | ||
| General & Administrative Expenses | $4.8M | $7.8M | $8.9M | ||
| Salaries & Wages | -- | $2.6M | $2.7M | ||
| Depreciation & Amortization | $27.4K | $27.4K | $27.4K | ||
| Depreciation & Amortization | $27.4K | $27.4K | $27.4K | ||
| Other Operating Expenses | $-525.0K | -- | -- | ||
| OPERATING INCOME | |||||
| Operating income | $-9.8M | $-7.9M | $-17.2M | ||
| EBITDA | $-9.3M | $-7.2M | $-15.6M | ||
| NON-OPERATING ITEMS | |||||
| Other Income/Expense | $-3.0M | $-639.4K | $-1.6M | ||
| Other Special Charges | $63.7K | $639.4K | $1.6M | ||
| PRE-TAX INCOME | |||||
| EBIT | $-9.3M | $-7.3M | $-15.6M | ||
| Pre-Tax Income | $-12.2M | $-7.3M | $-15.6M | ||
| INCOME TAX | |||||
| Tax Provision | -- | $723.9K | $-720.3K | ||
| NET INCOME | |||||
| Net Income | $-12.2M | $-8.0M | $-14.9M | ||
| Net Income (Continuing Operations) | $-12.2M | $-8.0M | $-14.9M | ||
| Net Income (Discontinued Operations) | $-12.2M | $-8.0M | $-14.9M | ||
| Net Income (Common Stockholders) | $-12.2M | $-8.0M | $-14.9M | ||
| Normalized Income | -- | -- | $-16.3M | ||
| TOTALS | |||||
| Total Expenses | $9.3M | $13.9M | $20.8M | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $2.6M | $10.2M | $15.2M | ||
| Average Shares Outstanding (Diluted) | $2.6M | $10.2M | $15.2M | ||
| Shares Outstanding | $9.9M | $14.5M | $16.7M | ||
| Basic EPS | $-4.73 | $-0.79 | $-0.98 | ||
| Basic EPS (Continuing Operations) | $-4.73 | $-0.79 | $-0.98 | ||
| Diluted EPS | $-4.73 | $-0.79 | $-0.98 | ||
| Diluted EPS (Continuing Operations) | $-4.73 | $-0.79 | $-0.98 | ||
| OTHER METRICS | |||||
| Net Income From Other Gains Losses | $-2.5M | -- | -- | ||
| Other Gand A | $4.8M | $7.8M | $8.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | COYA | $6.06 | -4.1% | 93.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |